Chief Development Officer · SANGAMO THERAPEUTICS, INC (SGMOQ)

Nathalie Dubois-Stringfellow

A named executive officer of SANGAMO THERAPEUTICS in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,132,369

Salary $453,600Stock awards $323,974

FY2023: $1,027,105

4th of 4 named executive officers at Sangamo Therapeutics by FY2024 total.

4 named officers on file for SANGAMO THERAPEUTICS, FY2024

Nathalie Dubois-Stringfellow’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how SANGAMO THERAPEUTICS’s whole pay program stands against its peers

  • SANGAMO THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SGMOQ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2025 (DEF 14A).

Free

Get Nathalie Dubois-Stringfellow’s full pay file as a PDF — free

More than this page: up to 10 years of Nathalie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Nathalie Dubois-Stringfellow compensation by year

SANGAMO THERAPEUTICS Summary Compensation Table · all 2 fiscal years held
In US dollars, as SANGAMO THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$453,600$453,600
Bonus$0$0
Stock awards$142,145$323,974
Option awards$425,060$0
Non-equity incentive$0$348,365
Pension and deferred compensation$0$0
All other$6,300$6,430
Total$1,027,105$1,132,369

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SANGAMO THERAPEUTICS, INC DEF 14A filed April 30, 2025, accession 0001628280-25-020773, and prior-year filings.

How this page was built: the SANGAMO THERAPEUTICS, INC filed document, accession 0001628280-25-020773. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.

$1.0M
$1.1M
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU712,500$726,750—
RSU25,049$25,550—
RSU4,229$4,314—
Option109,102—$2.66
Option7,611—$5.90
Option2,000—$11.19

Per the Outstanding Equity Awards at Fiscal Year-End table in SANGAMO THERAPEUTICS, INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

SANGAMO THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Alexander MacraeChief Executive Officer$2,457,450
Prathyusha DuraibabuChief Financial Officer$1,186,045
Scott WilloughbyChief Legal Officer & Corporate Secretary (5)$1,139,794
Nathalie Dubois-Stringfellow · this pageChief Development Officer$1,132,369

The full SANGAMO THERAPEUTICS compensation record

free company brief

This page is one person within SANGAMO THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SANGAMO THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nathalie Dubois-Stringfellow's compensation dossier · One-time report. No refunds.